SCRC News Alert Scripsamerica Inc (SCRC) 0.0900 10/01/2014 0

New Post Public Reply Private Reply Replies (0) Message Board

Oct 1, 2014 at 4:02 AM

Scripsamerica Inc (SCRC) 0.0900 $SCRC

ScripsAmerica Expands Specialty Pharmacy Operations to Include 12 Additional States Through New Sourcing Agreement
Marketwire - Tue Sep 16, 7:02AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has entered into a prescription sourcing agreement with Ohio-based Jungle Jim's International Market, which has pharmacy licenses in several states.

ScripsAmerica Expands Specialty Pharmacy Operations Through Prescription Sourcing Agreement With United Apothecary, Inc.
Marketwire - Mon Sep 08, 7:03AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has signed a prescription sourcing agreement with United Apothecary, Inc., a pharmacy based in Oak Ridge, TN.

ScripsAmerica's Specialty Pharmacy Continues Revenue Growth With $4.9 Million in Approved Orders for August
Marketwire - Wed Sep 03, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,867,637 in approved orders during the month of August 2014, marking its fifth consecutive month of sales growth.

ScripsAmerica Comments on 10-Q for the Second Quarter of 2014
Marketwire - Mon Aug 18, 7:01AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), today commented on the Company's recent 10-Q filing for the second quarter ended June 30, 2014.

Ironridge Global IV, Ltd. Successfully Obtains Final Enforcement Order Against ScripsAmerica, Inc.
ACCESSWIRE - Wed Aug 13, 3:31PM CDT
Los Angeles, CA / ACCESSWIRE / August 13, 2014 / Ironridge Global IV, Ltd. has obtained a final order against ScripsAmerica, Inc. (OTCBB: SCRC), fully upholding the original stipulated settlement agreement of the parties.

ScripsAmerica's Specialty Pharmacy Receives Approved Orders of $4.1 Million in July Marking Its Fourth Consecutive Month of Sales Growth
Marketwire - Mon Aug 04, 7:00AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $4,090,000 in approved orders during the month of July 2014.

ScripsAmerica's Managed Specialty Pharmacy on Pace for Record Month
Marketwire - Mon Jul 21, 7:01AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $1.5 million in approved prescription orders during the first half of July.

Wholesale Rx, ScripsAmerica's Equity Venture, Reports Significant YoY Revenue Growth During Q2 2014
Marketwire - Mon Jul 14, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $696,808 in orders during the quarter ended June 30, 2014 compared to $26,000 during the same quarter in 2013, prior to ScripsAmerica's involvement with the company.

ScripsAmerica's Equity Venture, Wholesale Rx, Reports 93% Revenue Growth During the First Quarter of 2014
Marketwire - Wed Jul 09, 7:30AM CDT
ScripsAmerica Inc. (OTCBB: SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," reported quarterly revenue growth of 93% from Q4 2013 to Q1 2014.

ScripsAmerica's Managed Specialty Pharmacy Receives Approved Orders of $2.7 Million in June
Marketwire - Mon Jul 07, 7:30AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company's managed specialty pharmacy reported $2,706,709 in prescription approved orders during the month of June.

ScripsAmerica Completes Prepayment of Outstanding Convertible Debt
Marketwire - Mon Jun 23, 8:15AM CDT
ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company has completed the prepayment of its outstanding convertible debt.

ScripsAmerica Issues Second Payment on Largest Convertible Note
GlobeNewswire - Wed Apr 02, 8:43AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has issued the second payment due on its convertible note with the largest principal and closest conversion date.

ScripsAmerica Reports March Revenue of Over $494,000 for Its Managed Specialty Pharmacy
GlobeNewswire - Tue Apr 01, 8:25AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the specialty pharmacy it recently entered into a management agreement with recorded $494,643 in prescription sales for the month of March.

ScripsAmerica Prepays $50,000 Convertible Promissory Note
GlobeNewswire - Mon Mar 31, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced the prepayment of an outstanding convertible note in the principal amount of $50,000.

ScripsAmerica's Pharmaceutical Equity Venture, Wholesale Rx, Continues Revenue Growth in February
GlobeNewswire - Mon Mar 24, 7:33AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company's equity venture, Wholesale Rx "WRx," received and processed $313,904 in orders during the month of February.

ScripsAmerica Prepays Another Convertible Promissory Note
GlobeNewswire - Mon Mar 17, 7:30AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the entire balance of an outstanding convertible promissory note with a principal amount of $50,000.

ScripsAmerica Announces Prepayment of Convertible Promissory Note
GlobeNewswire - Wed Mar 12, 7:46AM CDT
ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company has prepaid the balance of an outstanding convertible promissory note with a principal amount of $40,000.

ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.

ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.

ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Layne's Chicken Fingers Expands with Brownsville Opening

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...